<bill session="118" type="h" number="4626" updated="2024-08-20T20:14:32Z">
  <state datetime="2023-07-13">REFERRED</state>
  <status>
    <introduced datetime="2023-07-13"/>
  </status>
  <introduced datetime="2023-07-13"/>
  <titles>
    <title type="display">OTC Act of 2023</title>
    <title type="short" as="introduced">Orally Taken Contraception Act of 2023</title>
    <title type="short" as="introduced">OTC Act of 2023</title>
    <title type="official" as="introduced">To encourage sponsors of oral contraceptive drugs to submit applications for the approval of such drugs as over-the-counter, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001215"/>
  <cosponsors>
    <cosponsor bioguide_id="B000740" joined="2023-07-13"/>
    <cosponsor bioguide_id="C001135" joined="2023-07-13"/>
    <cosponsor bioguide_id="G000596" joined="2023-07-13"/>
    <cosponsor bioguide_id="H001086" joined="2023-07-13"/>
    <cosponsor bioguide_id="H001091" joined="2023-09-14"/>
    <cosponsor bioguide_id="K000399" joined="2023-07-13"/>
    <cosponsor bioguide_id="K000397" joined="2023-07-13"/>
    <cosponsor bioguide_id="M000194" joined="2023-07-13"/>
    <cosponsor bioguide_id="M000317" joined="2023-07-13"/>
    <cosponsor bioguide_id="S000168" joined="2023-07-13"/>
  </cosponsors>
  <actions>
    <action datetime="2023-07-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-07-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-07-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Family planning and birth control"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Prescription drugs"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2024-08-20T20:13:37Z" status="Introduced in House">Orally Taken Contraception Act of 2023 or the OTC Act of 2023

This bill requires the Food and Drug Administration (FDA)&#160;to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the&#160;labeling could be improved.</summary>
</bill>
